Clinical trial reportCancer discoveryPublished
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Cancer discovery
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasm Recurrence, Local; Pyridones; Pyrimidinones; Protein Kinase Inhibitors; Treatment Outcome; Hematopoietic Stem Cell Transplantation; Drug Resistance, Neoplasm; Child; Child, Preschool; Infant; Female
- PubMed ID
- 38867349
- PubMed Central ID
- PMC11374478
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked